Arzerra
List of products in the National Drug Code with proprietary name arzerra. Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0078-0669 | Arzerra | Novartis Pharmaceuticals Corporation | ||||
| 0078-0690 | Arzerra | Novartis Pharmaceuticals Corporation | ||||
| 0173-0808 | Arzerra | Glaxosmithkline Llc | ||||
| 0173-0821 | Arzerra | Glaxosmithkline Llc |
